Literature DB >> 24639356

Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression.

Jonathan S Boomer1, Christine M Deppong, Dulari D Shah, Traci L Bricker, Jonathan M Green.   

Abstract

CD28 is a critical regulator of T cell function, augmenting proliferation, cytokine secretion, and cell survival. Our previous work using knockin mice expressing point mutations in CD28 demonstrated that the distal proline motif was primarily responsible for much of CD28 function, whereas in marked contrast to prior studies, mutation of the PI3K-binding motif had little discernible effect. In this study, we examined the phenotype of mice in which both motifs are simultaneously mutated. We found that mutation of the PYAP motif unmasks a critical role for the proximal tyrosine motif in regulating T cell proliferation and expression of Bcl-xL but not cytokine secretion. In addition, we demonstrated that, although function is more severely impaired in the double mutant than in either single mutant, there remained residual CD28-dependent responses, definitively establishing that additional motifs can partially mediate CD28 function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639356      PMCID: PMC3994466          DOI: 10.4049/jimmunol.1301240

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  A point mutation in CD28 distinguishes proliferative signals from survival signals.

Authors:  K Okkenhaug; L Wu; K M Garza; J La Rose; W Khoo; B Odermatt; T W Mak; P S Ohashi; R Rottapel
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Requirement for CD28 in the effector phase of allergic airway inflammation.

Authors:  Stephanie L Kimzey; Pingfan Liu; Jonathan M Green
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

Review 3.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

4.  CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.

Authors:  D Cefai; Y C Cai; H Hu; C Rudd
Journal:  Int Immunol       Date:  1996-10       Impact factor: 4.823

5.  CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β.

Authors:  Christine M Deppong; Traci L Bricker; Brandy D Rannals; Nico Van Rooijen; Chyi-Song Hsieh; Jonathan M Green
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

6.  CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs.

Authors:  Antonio J Pagán; Marion Pepper; H Hamlet Chu; Jonathan M Green; Marc K Jenkins
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

7.  Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling.

Authors:  H H Kim; M Tharayil; C E Rudd
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

8.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.

Authors:  F Pagès; M Ragueneau; R Rottapel; A Truneh; J Nunes; J Imbert; D Olive
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

9.  Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.

Authors:  Lindzy F Dodson; Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Julia Sim; Traci L Bricker; John H Russell; Jonathan M Green
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

10.  Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells.

Authors:  K E Truitt; C M Hicks; J B Imboden
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  10 in total

1.  A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.

Authors:  Seung Ho Lee; Ji Sun Kim; Jaesang Kim; Seok Jin Kim; Won Seog Kim; Sanghyuk Lee; Young Hyeh Ko; Hae Yong Yoo
Journal:  Haematologica       Date:  2015-09-24       Impact factor: 9.941

Review 2.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif.

Authors:  Cheryl H Rozanski; Adam Utley; Louise M Carlson; Matthew R Farren; Megan Murray; Lisa M Russell; Jayakumar R Nair; ZhengYu Yang; William Brady; Lee Ann Garrett-Sinha; Stephen P Schoenberger; Jonathan M Green; Lawrence H Boise; Kelvin P Lee
Journal:  J Immunol       Date:  2015-04-01       Impact factor: 5.422

Review 4.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

5.  Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Authors:  Jessica Dobbins; Etienne Gagnon; Jernej Godec; Jason Pyrdol; Dario A A Vignali; Arlene H Sharpe; Kai W Wucherpfennig
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

6.  Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.

Authors:  Noriaki Yoshida; Kay Shigemori; Nicholas Donaldson; Christopher Trevisani; Nicolas A Cordero; Kristen E Stevenson; Xia Bu; Fumiko Arakawa; Mai Takeuchi; Koichi Ohshima; Akinori Yoda; Samuel Y Ng; David M Weinstock
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

Review 7.  Cell Type-Specific Regulation of Immunological Synapse Dynamics by B7 Ligand Recognition.

Authors:  Joanna Brzostek; Nicholas R J Gascoigne; Vasily Rybakin
Journal:  Front Immunol       Date:  2016-02-04       Impact factor: 7.561

8.  B7-CD28 co-stimulation modulates central tolerance via thymic clonal deletion and Treg generation through distinct mechanisms.

Authors:  Masashi Watanabe; Ying Lu; Michael Breen; Richard J Hodes
Journal:  Nat Commun       Date:  2020-12-08       Impact factor: 14.919

Review 9.  Co-Stimulatory Receptor Signaling in CAR-T Cells.

Authors:  Mackenzie M Honikel; Scott H Olejniczak
Journal:  Biomolecules       Date:  2022-09-15

10.  Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand.

Authors:  Hong-Sheng Lim; Shaun-Paul Cordoba; Omer Dushek; Jesse Goyette; Alison Taylor; Christopher E Rudd; P Anton van der Merwe
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.